Drawing for TARGETED POWER YOU CAN TRUST

USPTO serial 86772432

TARGETED POWER YOU CAN TRUST

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
RAJA, AMER YASIN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TARGETED POWER YOU CAN TRUST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jonathan A. Hyman

JONATHAN A. HYMAN Knobbe Martens Olson & Bear Llp2040 Main St Fl 14Irvine, CA 92614-8214UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cancer; radioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radiopharmaceuticals for the treatment of cancer; radiopharmaceutical preparations for use in nuclear medicine; therapeutic agents for delivery of radioactive materials to target sites within the body for the treatment of cancer; beads in the nature of microscopic glass beads impregnated with radioactive pharmaceutical preparations for treatment of cancerous tumoursACTIVE—
010Radiotherapy apparatus; surgical and medical apparatus and instruments for delivery of radiopharmaceuticals and radioactive material to target sites within the body; implantable radiation therapy devices consisting of radioactive beads, namely, beads in the nature of microscopic radioactive beads for treatment of cancerous tumours; radioactive glass beads, namely, implantable radiation therapy devices consisting of radioactive beads; radioactive beads, namely, implantable radiation therapy devices consisting of radioactive glass beads administered for treatment of cancerous tumours; medical devices, apparatus and instruments for treating cancerACTIVE—
041Education services, namely, developing, arranging and conducting educational conferences and programmes and providing courses of instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science and medicine; training in the use and operation of medical devices, medical imaging apparatus and medical research apparatus and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions, and training programs in the fields of healthcare and medical diseases, disorders and related treatments; educational services, namely, providing non-downloadable webinars in the fields of healthcare and medical diseases, disorders and related treatments; training in the use of pharmaceutical products in the nature of pharmaceutical preparations for the treatment of cancer, radiotherapy substances for medical purposes for the treatment of cancer, radiopharmaceuticals for the treatment of cancer, radiopharmaceutical preparations for use in nuclear medicine, therapeutic agents for delivery of radioactive materials to target sites within the body for the treatment of cancer, implantable radiation therapy devices, radioactive beads, radiotherapy apparatus, surgical and medical apparatus and instruments for delivery of radiopharmaceuticals and radioactive material to target sites within the body, and medical devices, apparatus and instruments for treating cancer; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions, and training programs in the field of health; educational services, namely, providing non-downloadable webinars in the field of health; educational services, namely, conducting online and telephonic instruction and courses in the fields of health and medical issues; conducting educational seminars in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science and medicineACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 15, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 15, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 11, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 16, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 16, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 27, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 12, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 5, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 27, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 27, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 27, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 19, 2016DOCKASSIGNED TO EXAMINER—
Nov 24, 2015AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Nov 23, 2015ALIEASSIGNED TO LIE—
Nov 3, 2015PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Oct 5, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 2, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance